| 1 | MAGEA3
|
| MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
|
| Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J.
|
| Cancers (Basel) May 15;11(5):677. doi: 10.3390/cancers11050677 2019
|
| 2 | MAGEA3, MAGEB4, ODF4
|
| Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
|
| Afsharpad M, Nowroozi MR, Mobasheri MB, Ayati M, Nekoohesh L, Saffari M, Zendehdel K, Modarressi MH.
|
| Pathol Oncol Res. Jan;25(1):191-199. doi: 10.1007/s12253-017-0313-4. Epub 2017 Oct 20 2019
|
| 3 | GPC3, MAGEA1, MAGEA3
|
| MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.
|
| Gu L, Sang M, Yin D, Liu F, Wu Y, Liu S, Huang W, Shan B.
|
| Thorac Cancer 9(4):431-438. doi: 10.1111/1759-7714.12571. Epub 2018 Feb 12.
2018
|
| 4 | MAGEA3
|
| Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.
|
| Chen X, Wang L, Liu J, Huang L, Yang L, Gao Q, Shi X, Li J, Li F, Zhang Z, Zhao S, Zhang B, Van der Bruggen P, Zhang Y.
|
| Oncol Lett. Mar;13(3):1609-1618. doi: 10.3892/ol.2017.5665. Epub 2017 Feb 1 2017
|
| 5 | MAGEA2, MAGEA3, MAGEB2, MAGEC2, NXF2
|
| Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.
|
| Van Tongelen A, Loriot A, De Smet C.
|
| Cancer Lett. Jun 28;396:130-137. doi: 10.1016/j.canlet.2017.03.029. Epub 2017 Mar 22 2017
|
| 6 | MAGEA1, MAGEA2, MAGEA3, MAGEA5, MAGEA8
|
| The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice.
|
| Hou S, Xian L, Shi P, Li C, Lin Z, Gao X.
|
| Sci Rep. May 26;6:26735. doi: 10.1038/srep26735 2016
|
| 7 | MAGEA3
|
| MAGE-A3: an immunogenic target used in clinical practice.
|
| Esfandiary A, Ghafouri-Fard S.
|
| Immunotherapy 7(6):683-704. doi: 10.2217/imt.15.29. Epub 2015 Jun 23 2015
|
| 8 | MAGEA3
|
| MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
|
| Yin B, Zeng Y, Liu G, Wang X, Wang P, Song Y.
|
| Int J Clin Exp Pathol. May 15;7(6):2934-41. eCollection 2014 2014
|
| 9 | MAGEA3
|
| Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
|
| Dyrskjøt L, Zieger K, Kissow Lildal T, Reinert T, Gruselle O, Coche T, Borre M, Ørntoft TF.
|
| Br J Cancer Jun 26;107(1):116-22. doi: 10.1038/bjc.2012.215. Epub 2012 May 17 2012
|
| 10 | CTCFL, MAGEA2, MAGEA3, MAGEA4
|
| BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.
|
| Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA.
|
| Clin Cancer Res. Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10 2011
|
| 11 | MAGEA3, MAGEA4, MAGEA6, MAGEA8
|
| Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks.
|
| Lifantseva N, Koltsova A, Krylova T, Yakovleva T, Poljanskaya G, Gordeeva O.
|
| Stem Cells Int. 2011:795239. doi: 10.4061/2011/795239. Epub 2011 Jul 18 2011
|
| 12 | MAGEA1, MAGEA10, MAGEA12, MAGEA2, MAGEA3, MAGEA4
|
| Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
|
| Andrade VC, Vettore AL, Felix RS, Almeida MS, Carvalho F, Oliveira JS, Chauffaille ML, Andriolo A, Caballero OL, Zago MA, Colleoni GW.
|
| Cancer Immun 8:2.
2008
|
| 13 | CTAG1B, MAGEA3, MAGEA4
|
| Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
|
| Grah J, Samija M, Juretić A, Sarcević B, Sobat H.
|
| Coll Antropol 32(3):731-6.PMID: 18982744 2008
|
| 14 | MAGEA3
|
| The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
|
| Liu W, Cheng S, Asa SL, Ezzat S.
|
| Cancer Res 68(19):8104-12.PMID: 18829569 2008
|
| 15 | FGFR2, MAGEA3
|
| Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
|
| Zhu X, Asa SL, Ezzat S.
|
| Clin Cancer Res 14(7):1984-96.PMID: 18381936 2008
|
| 16 | CTAG1, MAGEA1, MAGEA3, MAGEA4, MAGEA6, MAGEC1, MAGEC2, SLCO6A1, SYCP1, TPTE
|
| Cancer-testis (CT) antigen expression in medulloblastoma.
|
| Oba-Shinjo SM, Caballero OL, Jungbluth AA, Rosemberg S, Old LJ, Simpson AJ, Marie SK.
|
| Cancer Immun 8:7. 2008
|
| 17 | MAGEA3
|
| Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
|
| Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
|
| J Invest Dermatol 127(9):2123-8. Epub 2007 May 10. 2007
|
| 18 | MAGEA1, MAGEA12, MAGEA2, MAGEA3, MBD1, MBD2, MECP2
|
| Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
|
| Wischnewski F, Friese O, Pantel K, Schwarzenbach H.
|
| Mol Cancer Res 5(7):749-59. 2007
|
| 19 | MAGEA1, MAGEA3
|
| Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
|
| Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
|
| J Invest Dermatol 127(9):2123-8. Epub 2007 May 10.PMID: 17495964 2007
|
| 20 | MAGEA1, MAGEA3
|
| 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
|
| Qiu G, Fang J, He Y.
|
| Clin Biochem 39(3):259-66. Epub 2006 Mar 6. 2006
|
| 21 | MAGEA1, MAGEA3
|
| Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
|
| Kim KH, Choi JS, Kim IJ, Ku JL, Park JG.
|
| World J Gastroenterol 12(35):5651-7.PMID: 17007017 2006
|
| 22 | MAGEA1, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA6
|
| MAGE-A gene expression pattern in primary breast cancer.
|
| Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Loning T, Janicke F, Pantel K.
|
| Cancer Res 61(18):6682-7. 2001
|
| 23 | MAGEA1, MAGEA3, PRAME
|
| The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
|
| Pellat-Deceunynck C, Mellerin MP, Labarriere N, Jego G, Moreau-Aubry A, Harousseau JL, Jotereau F, Bataille R.
|
| Eur J Immunol 30(3):803-9. 2000
|
| 24 | MAGEA1, MAGEA3
|
| Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
|
| Kariyama K, Higashi T, Kobayashi Y, Nouso K, Nakatsukasa H, Yamano T, Ishizaki M, Kaneyoshi T, Toshikuni N, Ohnishi T, Fujiwara K, Nakayama E, Terracciano L, Spagnoli GC, Tsuji T.
|
| Br J Cancer 81(6):1080-7 1999
|
| 25 | MAGEA3
|
| Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck.
|
| Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC, Yu TH.
|
| Anticancer Res 19(6B):5037-42. 1999
|
| 26 | MAGEA1, MAGEA10, MAGEA2, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9
|
| Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
|
| Serrano A, Lethé B, Delroisse JM, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T.
|
| Int J Cancer 83(5):664-9.
1999
|
| 27 | MAGEA1, MAGEA2B, MAGEA3
|
| Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2.
|
| Ofuji S, et al.
|
| Anticancer Res 18 : 3639-3644. 1998
|
| 28 | MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
|
| The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28.
|
| Rogner UC, Wilke K, Steck E, Korn B, Poustka A.
|
| Genomics 29(3):725-31. 1995
|
| 29 | MAGEA@, MAGEA1, MAGEA2B, MAGEA3
|
| Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter : implications for MAGE immunotherapy.
|
| Oaks MK, et al.
|
| Cancer Res 54 : 1627-1629. 1994
|
| 30 | MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
|
| Structure, chromosomal localization, and expression of 12 genes of the MAGE family.
|
| De Plaen E, et al.
|
| Immunogenetics 40 : 360-369. 1994
|
| 31 | MAGEA1, MAGEA3, MAGEA12
|
| Cloning and analysis of MAGE-1-related genes.
|
| Ding M, et al.
|
| Biochem Biophys Res Commun 202 : 549-555. 1994
|